Consumer Medicine Information
What is in this leaflet
This leaflet answers some common questions about METOPROLOL IV MYLAN. It does not
contain all the available information. It does not take the place of talking to your
doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you being
given METOPROLOL IV MYLAN against the benefits they expect it will have for you.
If you have any concerns about being given this medicine, ask your doctor, nurse or
Keep this leaflet with the medicine.
You may need to read it again.
What METOPROLOL IV MYLAN is used for
Your medicine contains metoprolol tartrate as the active ingredient. This medicine
belongs to a group of medicines called beta-blockers.
Metoprolol tartrate is used to treat an irregular heartbeat, also known as arrhythmia,
which means that there is a disturbance of the heart's normal rhythm or beat.
Arrhythmias may be caused by numerous factors, including some heart diseases, an overactive
thyroid gland or chemical imbalances. After a heart attack there is also a chance
of developing an arrhythmia.
Metoprolol tartrate helps to restore your heart beat to a more normal rate, particularly
if it is beating very fast.
Ask your doctor if you have any questions about why this medicine has been prescribed
Your doctor may have prescribed it for another reason.
This medicine is not addictive.
Before you are given METOPROLOL IV MYLAN
When you must not be given it
You should not be given METOPROLOL IV MYLAN if you have an allergy to:
any medicine containing metoprolol tartrate
any other beta-blocker medicine
any of the ingredients listed at the end of this leaflet
Some of the symptoms of an allergic reaction may include:
shortness of breath
wheezing or difficulty breathing
swelling of the face, lips, tongue or other parts of the body
rash, itching or hives on the skin
Do not take this medicine if you are pregnant.
It may affect your developing baby if you are given it early in pregnancy of in the
last weeks before your baby is due.
Do not breast-feed if you are taking this medicine.
The active ingredient in METOPROLOL IV MYLAN passes into breast milk and there is
a possibility that your baby may be affected.
Do not give this medicine to children.
Safety and effectiveness of this medicine in children have not been established.
Do not use this medicine after the expiry date printed on the pack or if the packaging
s torn or shows signs of tampering.
It may have no effect at all, or worse, an entirely unexpected effect if it is used
after the expiry date.
Before you are given it
Tell your doctor if you have allergies to any other medicines, foods, preservatives
Tell your doctor if you have or have had any of the following medical conditions:
an overactive thyroid gland
certain types of angina
any other heart problems
Tell your doctor if you are pregnant or plan to become pregnant or are breast-feeding.
Your doctor can discuss with you the risks and benefits involved.
If you have not told your doctor about any of the above, tell them before you are
given METOPROLOL IV MYLAN.
Taking other medicines
Tell your doctor or pharmacist if you are taking any other medicines, including any
that you get without a prescription from your pharmacy, supermarket or health food
Some medicines and METOPROLOL IV MYLAN may interfere with each other. These include:
other beta-blocker medicines, including beta-blocker eye drops
medicines used to treat high blood pressure or angina
medicines used to treat heart problems
insulin and tablets used to treat diabetes
medicines used to treat depression
These medicines may be affected by METOPROLOL IV MYLAN or may affect how well it works.
You may need different amounts of your medicines or you may need to take different
Your doctor, nurse and pharmacist have more information on medicines to be careful
with or avoid while using this medicine.
How METOPROLOL IV MYLAN is given
Follow all directions given to you by your doctor or pharmacist carefully.
They may differ from the information contained in this leaflet.
METOPROLOL IV MYLAN is given as a slow injection into a vein.
It should only be given by a doctor or nurse.
Your doctor will decide what dose and for how long you will receive METOPROLOL IV
MYLAN. This will depend on your condition and other factors, such as your weight.
To begin treatment, up to 5 mg of METOPROLOL IV MYLAN is given at a rate of 1 to 2
mg per minute. This dose may be repeated at 5-minute intervals until a satisfactory
effect is achieved.
Your blood pressure and ECG will be monitored during treatment.
If you are given too much
As this is given by a doctor or nurse it is unlikely that you will be given too much
METOPROLOL IV MYLAN.
However, if you are accidentally given too much METOPROLOL IV MYLAN you may experience
nausea, vomiting, convulsions, an extreme slowing of the heartbeat, lowered blood
pressure, possible heart failure and breathing difficulties.
In extreme cases, your skin may turn blue, and you may go into shock, unconsciousness
Your doctor has information on how to recognise and treat an overdose.
Tell your doctor or nurse as soon as possible if you do not feel well while you are
being given METOPROLOL IV MYLAN.
This medicine helps most people with an irregular heartbeat, but it may have unwanted
side effects in a few people. All medicines can have side effects. Sometimes they
are serious, most of the time they are not. You may need medical treatment if you
get some of the side effects.
If you are over 65 years of age you may have an increased chance of getting side effects.
Do not be alarmed by the following list of side effects. You may not experience any
Ask your doctor or nurse to answer any questions you may have.
Tell your doctor or nurse if you notice any of the following and they worry you:
swelling, burning sensation, changes in skin colour or texture where you had the injection
swelling or pain in a vein
headache, tiredness, drowsiness
aches and pains, painful joints
nausea (feeling sick), vomiting
weakness, lack of energy
stomach upset, diarrhoea or constipation
dry mouth, changes in taste sensation
difficulty sleeping, nightmares
confusion, short-term memory loss, inability to concentrate
increased sweating, runny or blocked nose
These side effects are usually mild.
Tell your doctor or nurse as soon as possible if you notice any of the following:
dizziness, light-headedness or fainting especially on standing up
tingling or "pins and needles"
skin rash or worsening of psoriasis
symptoms of sunburn happening more quickly than before
abnormal thinking or hallucinations
buzzing or ringing in the ears, deafness
irritated eyes or blurred vision
These are serious side effects. You may need medical attention. Serious side effects
If any of the following happen, tell your doctor or nurse immediately:
shortness of breath, being less able to exercise
swelling of the ankles, feet or legs
chest tightness, wheezing, noisy breathing
chest pain, changes in heart rate or palpitations
swelling of the face, lips, tongue or throat
yellowing of the skin or eyes (jaundice), generally feeling unwell
constant "flu-like" symptoms with tiredness or lack of energy
These are very serious side effects. You may need urgent medical attention or hospitalisation.
These side effects are rare.
Tell your doctor or pharmacist if you notice anything that is making you feel unwell.
Other side effects not listed above may also occur in some people.
After being given METOPROLOL IV MYLAN
METOPROLOL IV MYLAN will be stored in the hospital pharmacy or on the ward.
The medicine is kept in a cool, dry place, protected from light, where the temperature
stays below 25°C.
What METOPROLOL IV MYLAN looks like:
METOPROLOL IV MYLAN is a clear liquid packaged in 5 mL glass vials containing the
active ingredient, metoprolol tartrate.
The medicine comes in packs of 5 vials.
Each vial of METOPROLOL IV MYLAN contains 5 mg of metoprolol tartrate as the active
The vials also contain sodium chloride and water for injections.
Alphapharm Pty Limited
Level 1, 30 The Bond
30-34 Hickson Road
Millers Point NSW 2000
Australian Registration Number:
AUST R 204665
This leaflet was prepared in August 2019.
metoprolol IV Mylan_cmi\Aug19/00